These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11518466)

  • 1. Low pO2 and beta-estradiol induce VEGF in MCF-7 and MCF-7-5C cells: relationship to in vivo hypoxia.
    Maity A; Sall W; Koch CJ; Oprysko PR; Evans SM
    Breast Cancer Res Treat; 2001 May; 67(1):51-60. PubMed ID: 11518466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
    Ruohola JK; Valve EM; Karkkainen MJ; Joukov V; Alitalo K; Härkönen PL
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):29-40. PubMed ID: 10375015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer.
    Takei H; Lee ES; Jordan VC
    Breast Cancer; 2002; 9(1):39-42. PubMed ID: 12196720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor gene expression in the human breast cancer cell line MX-1 is controlled by O2 availability in vitro and in vivo.
    Marxsen JH; Schmitt O; Metzen E; Jelkmann W; Hellwig-Bürgel T
    Ann Anat; 2001 May; 183(3):243-9. PubMed ID: 11396794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia.
    Bausero P; Ben-Mahdi M; Mazucatelli J; Bloy C; Perrot-Applanat M
    Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2033-42. PubMed ID: 11045935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen induces hypoxia in MCF-7 xenografts.
    Evans SM; Koch CJ; Laughlin KM; Jenkins WT; Van Winkle T; Wilson DF
    Cancer Res; 1997 Nov; 57(22):5155-61. PubMed ID: 9371518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo.
    Guo P; Fang Q; Tao HQ; Schafer CA; Fenton BM; Ding I; Hu B; Cheng SY
    Cancer Res; 2003 Aug; 63(15):4684-91. PubMed ID: 12907650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor.
    McLeskey SW; Tobias CA; Vezza PR; Filie AC; Kern FG; Hanfelt J
    Am J Pathol; 1998 Dec; 153(6):1993-2006. PubMed ID: 9846989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
    Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y
    Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
    Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
    Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
    Applanat MP; Buteau-Lozano H; Herve MA; Corpet A
    Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.
    Zhang HT; Craft P; Scott PA; Ziche M; Weich HA; Harris AL; Bicknell R
    J Natl Cancer Inst; 1995 Feb; 87(3):213-9. PubMed ID: 7535859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia and VEGF mRNA expression in human tumors.
    Ziemer LS; Koch CJ; Maity A; Magarelli DP; Horan AM; Evans SM
    Neoplasia; 2001; 3(6):500-8. PubMed ID: 11774032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia reduces hormone responsiveness of human breast cancer cells.
    Kurebayashi J; Otsuki T; Moriya T; Sonoo H
    Jpn J Cancer Res; 2001 Oct; 92(10):1093-101. PubMed ID: 11676860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
    Osipo C; Meeke K; Cheng D; Weichel A; Bertucci A; Liu H; Jordan VC
    Int J Oncol; 2007 Feb; 30(2):509-20. PubMed ID: 17203234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP.
    Miyamoto N; Mandai M; Takagi H; Suzuma I; Suzuma K; Koyama S; Otani A; Oh H; Honda Y
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2007-14. PubMed ID: 12037012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens.
    Coradini D; Pellizzaro C; Speranza A; Daidone MG
    Cell Mol Life Sci; 2004 Jan; 61(1):76-82. PubMed ID: 14704855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo.
    Garvin S; Dabrosin C
    Cancer Res; 2003 Dec; 63(24):8742-8. PubMed ID: 14695189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.
    Kurebayashi J; Otsuki T; Kurosumi M; Soga S; Akinaga S; Sonoo H
    Jpn J Cancer Res; 2001 Dec; 92(12):1342-51. PubMed ID: 11749701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.